HCI Group Increases Quarterly Cash Dividend 7.1% to 37.5 Cents
Apr 17, 2018 12:01 pm UTC| Business
TAMPA, Fla., April 17, 2018 -- HCI Group, Inc. (NYSE:HCI) has declared a regular quarterly cash dividend in the amount of 37.5 cents per common share for the second quarter of 2018, which represents a 7.1% increase over...
Apr 17, 2018 12:01 pm UTC| Business
TORONTO, ON, April 17, 2018 -- Easton Pharmaceuticals Inc. (OTC: EAPH) announces it is moving towards a letter of intent after initiating negotiations with 2 AMPR applicants, one having received a Health Canada...
North American Company for Life and Health Insurance launches new Builder Plus IUL
Apr 17, 2018 12:01 pm UTC| Business
CHICAGO, April 17, 2018 -- North American Company for Life and Health Insurance® announced the release of a new Indexed Universal Life (IUL) insurance product. The new Builder Plus IUL is a permanent life insurance...
Innovest Global Inc. $932K in Current Assets and Cancelled 50 Million Shares, Q1 Highlights
Apr 17, 2018 12:01 pm UTC| Business
CLEVELAND, April 17, 2018 -- Innovest Global Inc. (OTC PINK:IVST) reports over $600K in cash on hand and $708K in first quarter revenue. Innovests exit from mining cancelled 50 million shares. Financials posted...
Melissa Powers Native Data Quality for Oracle Users
Apr 17, 2018 12:01 pm UTC| Business
RANCHO SANTA MARGARITA, Calif., April 17, 2018 -- Melissa, a leading provider of global contact data quality and identity verification solutions, today advocated native data quality in Oracle platforms. Melissa’s active...
With Launch of Seclore Data Classification, Seclore Expands Data-Centric Security Offerings
Apr 17, 2018 12:01 pm UTC| Business
MILPITAS, Calif., April 17, 2018 -- Seclore announces the launch of Seclore Data Classification, expanding its Rights Management leadership to delivering integrated data-centric security. By integrating classification...
Apr 17, 2018 12:01 pm UTC| Business
MADISON, Wis., April 17, 2018 -- Cellectar Biosciences (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer,...